CoChat

Relationship between clone metrics and clinical outcome in clonal cytopenia

Open access
Gallì, Anna, Todisco, Gabriele, Catamo, Eulalia, Sala, Cinzia, Elena, Chiara, Pozzi, Sara, Bono, Elisa, Ferretti, Virginia Valeria, Rizzo, Ettore, Molteni, Elisabetta, Zibellini, Silvia, Sarchi, Martina, Boveri, Emanuela, Ferrari, Jacqueline, Fiorelli, Nicolas, Camaschella, Clara, Gasparini, Paolo, Toniolo, Daniela, Cazzola, Mario, Malcovati, Luca · 2021 · Blood
Cited by 104

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Clonal cytopenia of undetermined significance (CCUS) is associated with an increased risk of developing a myeloid neoplasm with myelodysplasia (MN). To identify the features of the mutant clone(s) that is associated with clinical phenotype and progression, we studied the following cohorts of individuals: 311 patients with idiopathic cytopenia of undetermined significance (ICUS), 532 community-dwelling individuals without hematologic phenotype (n = 355) or with unexplained anemia (n = 177), and 592 patients with overt MN. Ninety-two of 311 (30%) patients with ICUS carried a somatic genetic lesion that signaled CCUS. Clonal hematopoiesis (CH) was detected in 19.7% and 27.7% of nonanemic and anemic community-dwelling individuals, respectively. Different mutation patterns and variant allele frequencies (VAFs) (clone metrics parameters) were observed in the conditions studied. Recurrent mutation patterns exhibited different VAFs associated with marrow dysplasia (0.17-0.48), indicating variable clinical expressivity of mutant clones. Unsupervised clustering analysis based on mutation profiles identified 2 major clusters, characterized by isolated DNMT3A mutations (CH-like cluster) or combinatorial mutation patterns (MN-like cluster), and showing different overall survival (HR, 1.8). In patients with CCUS, the 2 clusters had different risk of progression to MN (HR, 2.7). Within the MN-like cluster, distinct subsets with different risk of progression to MN were identified based on clone metrics. These findings unveil marked variability in the clinical expressivity of myeloid driver genes and underline the limitations of morphologic dysplasia for clinical staging of mutant hematopoietic clones. Clone metrics appears to be critical for informing clinical decision-making in patients with clonal cytopenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2021011323

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 104

Metadata

Authors
Gallì, A., Todisco, G., Catamo, E., Sala, C., Elena, C., Pozzi, S., Bono, E., Ferretti, V. V., Rizzo, E., Molteni, E., Zibellini, S., Sarchi, M., Boveri, E., Ferrari, J., Fiorelli, N., Camaschella, C., Gasparini, P., Toniolo, D., Cazzola, M., & Malcovati, L.
Venue
Blood
Published
2021-07-13
Volume
138
Issue
11
Pages
965-976
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W3182365126
Cited by
104
References
12
FWCI
11.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationship between clone metrics and clinical outcome in clonal cytopenia. https://app.cochat.ai/papers/10.1182/blood.2021011323
The paper
Gallì, A., Todisco, G., Catamo, E., Sala, C., Elena, C., Pozzi, S., Bono, E., Ferretti, V. V., Rizzo, E., Molteni, E., Zibellini, S., Sarchi, M., Boveri, E., Ferrari, J., Fiorelli, N., Camaschella, C., Gasparini, P., Toniolo, D., Cazzola, M., & Malcovati, L. (2021). Relationship between clone metrics and clinical outcome in clonal cytopenia. Blood. https://doi.org/10.1182/blood.2021011323

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.